Abstract
No abstract available
Funding Information
  • Federación Española de Enfermedades Raras
  • Instituto de Salud Carlos III (CP14CIII/00010, CP17CIII/00007, PI15/01451)
  • Pfizer (CT25-ESP01-01)

This publication has 10 references indexed in Scilit: